Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial.
暂无分享,去创建一个
C. Rübe | T. Wiegel | D. Bottke | U. Steiner | A. Siegmann | R. Golz | A. Semjonow | M. Stöckle | T. Kälble | H. Feldmann | M. Wirth | A. Hinke | W. Hinkelbein | K. Miller | R. Thamm | R. Engenhart-Cabillic | R. Hofmann | D. Bartkowiak | S. Störkel